Corrigendum to “Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein” [Toxicology and Applied Pharmacology 271 (2013) 144–145](S0041008X13002159)(10.1016/j.taap.2013.04.031);Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein

Toxicology and Applied Pharmacology

Volumn 271, Issue 2, 2013, Pages 144-155

  Song, Xiuming ^a   Yao, Jing ^a   Wang, Fei ^a   Zhou, Mi ^a   Zhou, Yuxin ^a   Wang, Hu ^a   Wei, Libin ^a   Zhao, Li ^a   Li, Zhiyu ^a   Lu, Na ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Degradation; Hypoxia inducible factor 1 (HIF 1 ); Wogonin

Indexed keywords

CD31 ANTIGEN; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OLIGONUCLEOTIDE; PACLITAXEL; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLINE DERIVATIVE; SURVIVIN; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; WOGONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CANCER THERAPY; CELL STRAIN HCT116; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELECTROPHORESIS; ELECTROPHORESIS MOBILITY SHIFT ASSAY; FEMALE; HUMAN; HUMAN CELL; HYDROXYLATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STABILITY; TUMOR XENOGRAFT;

EID: 84880619794     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2019.114762     Document Type: Erratum

References (35)

1. Auerbach R., Kubai L., Knighton D., Folkman J. A simple procedure for the long-term cultivation of chicken embryos. Dev. Biol. 1974, 41:391-394.
2. Chi Y.S., Lim H., Park H., Kim H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem. Pharmacol. 2003, 66:1271-1278.
3. Eguchi H., Ikuta T., Tachibana T., Yoneda Y., Kawajiri K. A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J. Biol. Chem. 1997, 272:17640-17647.
4. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16:4604-4613.
5. Gao Z., Huang K., Yang X., Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim. Biophys. Acta 1999, 1472:643-650.
6. Gu H., Wang X., Rao S., Wang J., Zhao J., Ren F.L., Mu R., Yang Y., Qi Q., Liu W., Lu N., Ling H., You Q., Guo Q. Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. Mol. Cancer Ther. 2008, 7:3298-3305.
7. Huang K.F., Zhang G.D., Huang Y.Q., Diao Y. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int. Immunopharmacol. 2012, 12:334-341.
8. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol. 2002, 64:1415-1424.
9. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
10. Jung C.R., Hwang K.S., Yoo J., Cho W.K., Kim J.M., Kim W.H., Im D.S. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat. Med. 2006, 12:809-816.
11. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 1999, 274:6519-6525.
12. Kapitsinou P.P., Haase V.H. The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death Differ. 2008, 15:650-659.
13. Kim D.M., Chung K.S., Choi S.J., Jung Y.J., Park S.K., Han G.H., Ha J.S., Song K.B., Choi N.S., Kim H.M., Won M., Seo Y.S. RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells. Int. J. Cancer 2009, 125:2520-2527.
14. Kimura Y., Okuda H., Ogita Z. Effects of flavonoids isolated from scutellariae radix on fibrinolytic system induced by trypsin in human umbilical vein endothelial cells. J. Nat. Prod. 1997, 60:598-601.
15. 2+-dependent endonuclease. Biochem. Pharmacol. 2002, 63:225-236.
16. Lee C.C., Liu K.J., Wu Y.C., Lin S.J., Chang C.C., Huang T.S. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation 2011, 34:209-221.
17. Li C., Lu N., Qi Q., Li F., Ling Y., Chen Y., Qin Y., Li Z., Zhang H., You Q., Guo Q. Gambogic acid inhibits tumor cell adhesion by suppressing integrin beta1 and membrane lipid rafts-associated integrin signaling pathway. Biochem. Pharmacol. 2011, 82:1873-1883.
18. Liu Y.V., Semenza G.L. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007, 6:656-659.
19. 2-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol. Cell 2007, 25:207-217.
20. Los M., Jansen G.H., Kaelin W.G., Lips C.J., Blijham G.H., Voest E.E. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab. Invest. 1996, 75:231-238.
21. Lu N., Yang Y., You Q.D., Ling Y., Gao Y., Gu H.Y., Zhao L., Wang X.T., Guo Q.L. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett. 2007, 258:80-89.
22. Lu N., Gao Y., Ling Y., Chen Y., Yang Y., Gu H.Y., Qi Q., Liu W., Wang X.T., You Q.D., Guo Q.L. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci. 2008, 82:956-963.
23. Lu Z., Lu N., Li C., Li F., Zhao K., Lin B., Guo Q. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicol. Lett. 2012, 209:211-220.
24. Ma S.C., Du J., But P.P., Deng X.L., Zhang Y.W., Ooi V.E., Xu H.X., Lee S.H., Lee S.F. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J. Ethnopharmacol. 2002, 79:205-211.
25. Medici D., Olsen B.R. Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. PLoS One 2012, 7:e42913.
26. Minet E., Mottet D., Michel G., Roland I., Raes M., Remacle J., Michiels C. Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 1999, 460:251-256.
27. Rehbein M., Kindler S., Horke S., Richter D. Two trans-acting rat-brain proteins, MARTA1 and MARTA2, interact specifically with the dendritic targeting element in MAP2 mRNAs. Brain Res. Mol. Brain Res. 2000, 79:192-201.
28. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
29. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 1997, 272:22642-22647.
30. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
31. Sherer D.M., Abulafia O. Angiogenesis during implantation, and placental and early embryonic development. Placenta 2001, 22:1-13.
32. Steel R., Doherty J.P., Buzzard K., Clemons N., Hawkins C.J., Anderson R.L. Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J. Biol. Chem. 2004, 279:51490-51499.
33. Xu Y., Feng L., Wang S., Zhu Q., Zheng Z., Xiang P., He B., Tang D. Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration. J. Ethnopharmacol. 2011, 137:359-370.
34. You K.M., Jong H.G., Kim H.P. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch. Pharm. Res. 1999, 22:18-24.
35. Zhang K., Guo Q.L., You Q.D., Yang Y., Zhang H.W., Yang L., Gu H.Y., Qi Q., Tan Z., Wang X. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression. Cancer Sci. 2008, 99:689-695.